These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 23045473)
1. Re: "The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women". Grant WB Am J Epidemiol; 2012 Nov; 176(9):838. PubMed ID: 23045473 [No Abstract] [Full Text] [Related]
2. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women. Neuhouser ML; Manson JE; Millen A; Pettinger M; Margolis K; Jacobs ET; Shikany JM; Vitolins M; Adams-Campbell L; Liu S; LeBlanc E; Johnson KC; Wactawski-Wende J Am J Epidemiol; 2012 Apr; 175(7):673-84. PubMed ID: 22362582 [TBL] [Abstract][Full Text] [Related]
3. Blood 25-hydroxyvitamin D levels and overall mortality in patients with colorectal cancer: a dose-response meta-analysis. Wang B; Jing Z; Li C; Xu S; Wang Y Eur J Cancer; 2014 Aug; 50(12):2173-5. PubMed ID: 24878065 [No Abstract] [Full Text] [Related]
4. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors? Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D and cancer: an overview on epidemiological studies. Ordóñez Mena JM; Brenner H Adv Exp Med Biol; 2014; 810():17-32. PubMed ID: 25207358 [TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927 [TBL] [Abstract][Full Text] [Related]
8. 25-hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies. Grant WB Anticancer Res; 2015 Feb; 35(2):1153-60. PubMed ID: 25667506 [TBL] [Abstract][Full Text] [Related]
9. Re: Prospective study of vitamin D and cancer mortality in the United States. Garland CF; Gorham ED; Baggerly CA; Garland FC J Natl Cancer Inst; 2008 Jun; 100(11):826-7. PubMed ID: 18505971 [No Abstract] [Full Text] [Related]
10. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862 [TBL] [Abstract][Full Text] [Related]
11. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. Grant WB J Photochem Photobiol B; 2010 Nov; 101(2):130-6. PubMed ID: 20570169 [TBL] [Abstract][Full Text] [Related]
12. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548 [TBL] [Abstract][Full Text] [Related]
13. Caution regarding 25-hydroxyvitamin D monitoring in women with breast cancer. Chlebowski RT J Clin Oncol; 2009 Aug; 27(24):e72-3; author reply e74. PubMed ID: 19620473 [No Abstract] [Full Text] [Related]
14. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Rejnmark L; Tietze A; Vestergaard P; Buhl L; Lehbrink M; Heickendorff L; Mosekilde L Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2655-60. PubMed ID: 19789365 [TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D levels and survival of colorectal cancer patients: a meta-analysis. Ou B; Zhao J; Guan S; Lu A Eur J Cancer; 2015 Apr; 51(6):786-8. PubMed ID: 25746389 [No Abstract] [Full Text] [Related]
16. Plasma vitamin D metabolites and risk of colorectal cancer in women. Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452 [TBL] [Abstract][Full Text] [Related]
17. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis. Garland CF; Gorham ED J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551 [TBL] [Abstract][Full Text] [Related]
18. Re: Calcium plus vitamin D supplementation and the risk of breast cancer. Olsen A; Egeberg R; Tjønneland A J Natl Cancer Inst; 2009 May; 101(9):690; author reply 690-1. PubMed ID: 19401545 [No Abstract] [Full Text] [Related]
19. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women. de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688 [TBL] [Abstract][Full Text] [Related]
20. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study. Song M; Konijeti GG; Yuan C; Ananthakrishnan AN; Ogino S; Fuchs CS; Giovannucci EL; Ng K; Chan AT Cancer Prev Res (Phila); 2016 Aug; 9(8):664-72. PubMed ID: 27246684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]